These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 3152560)

  • 1. [Evaluation of the therapeutic effectiveness of a piracetam plus dihydroergocristine combination in the treatment of vertigo].
    López Martínez R
    Acta Otorrinolaringol Esp; 1988; 39(4):287-8. PubMed ID: 3152560
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical trial of the use of the combination of piracetam and dihydroergocristine in vertigo from different causes].
    Ordosgoitia H; Castro C; Carbayeda M; Labella T
    An Otorrinolaringol Ibero Am; 1989; 16(3):271-9. PubMed ID: 2502041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of pharmacological treatment in the compensation of vertigo].
    Pons Rocher F
    An Otorrinolaringol Ibero Am; 1999; 26(3):271-91. PubMed ID: 10394686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical and therapeutic experience in 151 consecutive protocolized cases with vertigo syndrome of cervical origin. Comparative study of a cinnarizine and dihydroergocristine combination with a cinnarizine and dihydroergocristine plus anti-inflammatory agents combination].
    Bartual J; Vidal J; Magro E; Roquette J
    Acta Otorrinolaringol Esp; 1988; 39(5):331-8. PubMed ID: 3152492
    [No Abstract]   [Full Text] [Related]  

  • 5. The efficacy of piracetam in vertigo. A double-blind study in patients with vertigo of central origin.
    Oosterveld WJ
    Arzneimittelforschung; 1980; 30(11):1947-9. PubMed ID: 7006617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of piracetam in vertigo.
    Fernandes CM; Samuel J
    S Afr Med J; 1985 Nov; 68(11):806-8. PubMed ID: 4071329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of vertigo syndrome with Nootropil].
    Miszke A; Rapacz K
    Otolaryngol Pol; 1988; 42(5):312-7. PubMed ID: 3075732
    [No Abstract]   [Full Text] [Related]  

  • 8. [On the meaning of psychometrically operationalized therapeutic effects in the treatment of brain insufficiency phenomena caused by old age demonstrated by the "Nürnberger-Alters-Inventar" (author's transl)].
    Oswald WD; Matejcek M; Lukaschek K; Dennler HJ; Oswald B
    Arzneimittelforschung; 1982; 32(5):584-90. PubMed ID: 7201839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapeutic action of a combination of vincamine and piracetam in peripheral labyrinthine syndromes with a vascular component].
    Jiménez-Cervantes Nicolás JA; Ferrán Bernal J; Anula Suárez P; Gil Melgarejo JA
    An Otorrinolaringol Ibero Am; 1981; 8(2):131-60. PubMed ID: 7270822
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapeutic trial of nootropyl in otorhinolaryngology].
    Ammar-Khodja A
    Rev Laryngol Otol Rhinol (Bord); 1974; 95(9-10):697-700. PubMed ID: 4462173
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of therapeutic response to long-term treatment with lecithin versus piracetam plus lecithin in patients with Alzheimer's disease.
    Smith RC; Vroulis G; Johnson R; Morgan R
    Psychopharmacol Bull; 1984; 20(3):542-5. PubMed ID: 6433396
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pilot study of 2-pyrrolidon-acetamid (generic name: piracetam) (author's transl)].
    Tacke B; Freistein H; Kempf H; Windheuser A
    Pharmakopsychiatr Neuropsychopharmakol; 1975 Mar; 8(2):82-9. PubMed ID: 788004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Value of piracetam in the treatment of sudden idiopathic deafness. Preliminary report].
    Gersdorff M; Franceschi D
    Ann Otolaryngol Chir Cervicofac; 1986; 103(4):283-5. PubMed ID: 3777763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effectiveness of piracetam in tardive dyskinesia - double-blind cross-over controlled trial with a placebo].
    Kabes J; Sikora J; Starý O; Pisvejc J; Hanzlícek L
    Cesk Psychiatr; 1983 Oct; 79(5):339-45. PubMed ID: 6357509
    [No Abstract]   [Full Text] [Related]  

  • 15. [Experiences with piracetam in therapy resistant shoulder--arm syndrome].
    Schmitt HW
    Fortschr Med; 1977 Nov; 95(42):2578-80. PubMed ID: 72036
    [No Abstract]   [Full Text] [Related]  

  • 16. [Minimal brain dysfunction. III. Treatment (preliminary report)].
    Rafael Cruz H; Valadez MT
    Salud Publica Mex; 1987; 29(1):55-60. PubMed ID: 2885925
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of peripheral vascular diseases with dihydroergocristine].
    Moracchini PV; Alfano G; Melandri F
    Minerva Cardioangiol; 1978 Apr; 26(4):277-90. PubMed ID: 97601
    [No Abstract]   [Full Text] [Related]  

  • 18. The treatment of minocycline-induced brainstem vertigo by the combined administration of piracetam and ergotoxin.
    Claussen CF; Schneider D; Patil NP
    Acta Otolaryngol Suppl; 1989; 468():171-4. PubMed ID: 2635498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of piracetam on the brain-organic psychosyndrome in cerebrovascular insufficiency. Results of a double-blind study in 40 cases].
    Trabant R; Poljakovic Z; Trabant D
    Ther Ggw; 1977 Aug; 116(8):1504-21. PubMed ID: 331549
    [No Abstract]   [Full Text] [Related]  

  • 20. Piracetam in the treatment of post-concussional syndrome. A double-blind study.
    Hakkarainen H; Hakamies L
    Eur Neurol; 1978; 17(1):50-5. PubMed ID: 342247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.